Hou Chiat Ho
Chief Investment Officer bei Mirxes Holding Co., Ltd.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Zhou Lihan | M | 40 |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 Jahre |
Zou Ruiyang | M | 38 |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore.
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 Jahre |
Isaac Ho | M | - |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.
Deakin University
| 10 Jahre |
Too Heng-Phon | M | 65 |
Ark Bio Holding Pte Ltd.
Ark Bio Holding Pte Ltd. Financial ConglomeratesFinance Ark Bio Holding Pte Ltd. operates as an investment holding company. The firm offers end-to-end solutions focused on cancer early detection. The company was founded by Isaac Ho, Zhou Lihan and Zou Ruiyang in 2018 and is headquartered in Singapore.
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 10 Jahre |
Lee Meng Lim | M | 68 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 Jahre |
Tai San Noah Lim | M | 49 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 Jahre |
Lo Ling Ma | F | 39 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | - |
David Francis Capes | M | 64 |
MiRXES Pte Ltd.
MiRXES Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MiRXES Pte Ltd. is a held life science research tool provider and miRNA diagnostic test developer. Its products and services include IDEAL miRNA knowledge, IDEAL miRNA assays, knowledge panel profiling service, cutomization assay and premium biomarker discovery solution. The company was founded by Zhou Lihan, Zou Ruiyang, and Too Heng Phon and is headquartered in Singapore. | - |
Beng Lor Choo | M | 52 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 4 Jahre |
Yuet Chew Siow | F | 57 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 1 Jahre |
Da Liu | M | 53 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 Jahre |
Beilin Le | M | 35 |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 Jahre |
Wei Zhi Owyong | F | - |
Mirxes Holding Co., Ltd.
Mirxes Holding Co., Ltd. Financial ConglomeratesFinance Mirxes Holding Co., Ltd. operates as an investment holding company. It is engaged in developing and commercializing blood-based miRNA test kit products for the early detection of cancer and other diseases. The firm’s business segments include Infectious Diseases and Early Detection and Precision Multi-Omics. The Infectious Diseases segment engages in development, manufacture, supply of diagnostic kits and provision of infectious disease clinical testing. The Early Detection and Precision Multi-Omics involves in Development, manufacture, supply of diagnostic & life sciences products, and provision of research profiling, clinical testing and clinical services. The company was founded by Too Heng Phon, Zhou Lihan and Zou Ruiyang in 2014 and is headquartered in Singapore. | 3 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Zainal Hadi Has HB | M | 40 |
Deakin University
| 4 Jahre |
Fatt Chong Loh | M | 45 |
Deakin University
| 6 Jahre |
Ferdian Timur Satyagraha | M | 42 |
Deakin University
| 6 Jahre |
Kit Wai Wong | M | 54 |
Deakin University
| 2 Jahre |
Daniel Wyner | M | - |
Deakin University
| 5 Jahre |
Tuen Ting Cheung | M | 43 |
Deakin University
| 4 Jahre |
Rong Chang | F | 54 |
Deakin University
| 1 Jahre |
Soo Ching Lee | F | 47 |
Deakin University
| 4 Jahre |
Ya Jun Gao | M | 48 |
Deakin University
| 1 Jahre |
Boris Rozenvasser | M | - |
Deakin University
| 4 Jahre |
Dave Sharma | M | - |
Deakin University
| 1 Jahre |
Shiow Yin Sai | F | 41 |
Deakin University
| 4 Jahre |
Ka Wah Cheong | F | 46 |
Deakin University
| 4 Jahre |
Lorraine Chiroiu | F | - |
Deakin University
| 4 Jahre |
Tim Fuk Wong | M | 44 |
Deakin University
| 4 Jahre |
Andrew Tirtadjaja | M | 44 |
Deakin University
| 4 Jahre |
Kwong Chak Lee | M | 60 |
Deakin University
| 2 Jahre |
Yah Lien Chong | F | 53 |
Deakin University
| 2 Jahre |
Wey Heng Low | M | 43 |
Deakin University
| 4 Jahre |
Yi Hui Dai | M | 43 |
Deakin University
| 1 Jahre |
Yis Hu Tang | M | 53 |
Deakin University
| 1 Jahre |
Ahmad Fazril Mohamed Fauz | M | 41 |
Deakin University
| 4 Jahre |
See See Ng | F | 53 |
Deakin University
| 2 Jahre |
Joo Kiang Lau | M | 40 |
Deakin University
| 4 Jahre |
Ahmad Fazril Bin Mohd Fauzi | M | 40 |
Deakin University
| 4 Jahre |
Hon Kwong Mok | M | 57 |
Deakin University
| 2 Jahre |
Zhe Zhang | M | - |
Deakin University
| 4 Jahre |
Cindy Veronica Jong | F | 39 |
Deakin University
| 4 Jahre |
Jonathan O’Dea | M | 57 |
Deakin University
| 2 Jahre |
Li Xia Tu | F | 41 |
Deakin University
| 2 Jahre |
Qiu Dong Liu | M | 52 |
Deakin University
| 2 Jahre |
Jarrod Hughes | M | - |
Deakin University
| 3 Jahre |
Dhanuka Ranjith Samarasinghe | M | - |
Deakin University
| 4 Jahre |
Peter Sung | M | 39 |
Deakin University
| 4 Jahre |
Alexander J. Ziolkowski | M | - |
Deakin University
| 2 Jahre |
Mark Bernhard | M | 60 |
Deakin University
| 2 Jahre |
Pam Pugsley | F | - |
Deakin University
| 1 Jahre |
Catriona Forrester | F | - |
Deakin University
| 1 Jahre |
Lap Kei Cheung | M | 52 |
Deakin University
| 2 Jahre |
Nigel Dean | M | 70 |
Deakin University
| 3 Jahre |
Lee Francis Horobin | M | 52 |
Deakin University
| 2 Jahre |
Suhaimi bin Badrul Jamil | M | 61 |
Deakin University
| 2 Jahre |
Kwok Wan Lee | M | 57 |
Deakin University
| 2 Jahre |
Hoang Van Nguyen | M | 51 |
Deakin University
| 2 Jahre |
Jian Feng Cui | M | 51 |
Deakin University
| 2 Jahre |
Shuen Kong Liu | M | 52 |
Deakin University
| 2 Jahre |
Ka Fuk Cheng | M | 60 |
Deakin University
| 2 Jahre |
Gui Lin Zhao | M | 60 |
Deakin University
| 1 Jahre |
Man On Siu | M | 45 |
Deakin University
| 4 Jahre |
Tze Fan Wan | M | 59 |
Deakin University
| 2 Jahre |
Paul Davadass | M | 53 |
Deakin University
| 2 Jahre |
Simba Murahwi | M | - |
Deakin University
| 4 Jahre |
Tim Johnston | M | - |
Deakin University
| 4 Jahre |
Jamil bin Osman | M | 57 |
Deakin University
| 1 Jahre |
Chen Qian | M | 41 |
Deakin University
| 4 Jahre |
Vinh Thanh Le | M | 45 |
Deakin University
| 3 Jahre |
Wei Chuan Ang | M | 49 |
Deakin University
| 3 Jahre |
Sze Kean Tan | F | - |
Deakin University
| 1 Jahre |
Haw Choon Chiau | M | 41 |
Deakin University
| 4 Jahre |
Hai Wu Zhu | M | 58 |
Deakin University
| 1 Jahre |
Kim Goon Lam | M | 53 |
Deakin University
| 4 Jahre |
Kai Chi Wong | M | 51 |
Deakin University
| 2 Jahre |
Andrew Paul Stedwell | M | - |
Deakin University
| 2 Jahre |
Daniel Laurence | M | - |
Deakin University
| 3 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Australien | 65 | 84,42% |
Singapur | 13 | 16,88% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Hou Chiat Ho
- Persönliches Netzwerk